Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bristol-Myers Squibb Pharmaceutical Limited
Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 17/04/2012
PIL Reyataz 150 mg, 200 mg and 300mg Hard Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to drug interactions
Updated on 29/11/2011 and displayed until 17/04/2012
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
Updated on 09/09/2011 and displayed until 29/11/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/06/2011 and displayed until 09/09/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 05/04/2011 and displayed until 01/06/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
Updated on 12/08/2010 and displayed until 05/04/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 22/03/2010 and displayed until 12/08/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 18/01/2010 and displayed until 22/03/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 21/08/2009 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 22/04/2009 and displayed until 21/08/2009
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 12/03/2009 and displayed until 22/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 10/09/2008 and displayed until 12/03/2009
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 08/07/2008 and displayed until 10/09/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 19/05/2008 and displayed until 08/07/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Introduction of new strength
Updated on 05/03/2008 and displayed until 19/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 05/04/2007 and displayed until 05/03/2008
Reasons for adding or updating:
  • Change of contra-indications
  • Change to drug interactions
Updated on 09/02/2007 and displayed until 05/04/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 30/08/2006 and displayed until 09/02/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to storage instructions
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 14/08/2006 and displayed until 30/08/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 06/12/2005 and displayed until 14/08/2006
Reasons for adding or updating:
  • No reasons supplied
Updated on 26/05/2005 and displayed until 06/12/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  atazanavir sulfate